Promising COVID oral antiviral being co-researched by Healion ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
FREDERICK, Md., April 29, 2022 /PRNewswire-AsiaNet/ -- Healion Bio, a closely held biotechnology company, today announced a collaborative agreement to research a combination antiviral against SARS-CoV-2 and other deadly pathogens. The combination will include one of Healion Bio's protease inhibitors a...
Authors: LATEST ASIANET NEWS RELEASES